Stock photo from Pixabay
Italy green-lights Japanese Avigan drug trial to fight pandemic
The go-ahead of the Avigan trial was given by the Italian Minister of Health, Roberto Speranza.
After the meeting of the Technical-scientific Committee on March 24, and after an initial analysis of the available data relating to Avigan, Italy will be “developing an experimentation and research program to evaluate the impact of the drug in the early stages of the disease”.
Speranza said expectations for fighting the new Coronavirus are now pinned on the Japanese drug.
Councilor for the Budget Davide Caparini added: “It has been an over-the-counter drug that since 2014, in Japan, has been used to fight the flu and has given positive results, but it is still necessary to understand how much this drug can to be effective. We thank Minister Speranza who accepted our heartfelt appeal. The trial will start immediately in Lombardy.”
Produced by Toyama Chemical, a Fujifilm controlled company, favipiravir – a generic drug – has been administered to Covid-19 patients in China.
All rights reserved. You have permission to quote freely from the articles provided that the source (www.freewestmedia.com) is given. Photos may not be used without our consent.
Consider donating to support our work
Help us to produce more articles like this. FreeWestMedia is depending on donations from our readers to keep going. With your help, we expose the mainstream fake news agenda.
Keep your language polite. Readers from many different countries visit and contribute to Free West Media and we must therefore obey the rules in, for example, Germany. Illegal content will be deleted.
If you have been approved to post comments without preview from FWM, you are responsible for violations of any law. This means that FWM may be forced to cooperate with authorities in a possible crime investigation.
If your comments are subject to preview by FWM, please be patient. We continually review comments but depending on the time of day it can take up to several hours before your comment is reviewed.
We reserve the right to delete comments that are offensive, contain slander or foul language, or are irrelevant to the discussion.